529 related articles for article (PubMed ID: 2282513)
1. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
2. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
Herrick-Davis K; Titeler M
J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
[TBL] [Abstract][Full Text] [Related]
3. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
4. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
Harrington MA; Peroutka SJ
J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
[TBL] [Abstract][Full Text] [Related]
6. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
7. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
Oksenberg D; Peroutka SJ
Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
[TBL] [Abstract][Full Text] [Related]
9. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
Deliganis AV; Pierce PA; Peroutka SJ
Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
[TBL] [Abstract][Full Text] [Related]
10. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
Palego L; Marazziti D; Rotondo A; Batistini A; Lucacchini A; Naccarato AG; Bevilacqua G; Borsini F; Ladinsky H; Cassano GB
Neurochem Int; 1997 Feb; 30(2):149-57. PubMed ID: 9017662
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
Schlegel JR; Peroutka SJ
Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
[TBL] [Abstract][Full Text] [Related]
12. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
13. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
14. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
Iben LG; Mahle CD; Yocca FD
Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
[TBL] [Abstract][Full Text] [Related]
16. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
[TBL] [Abstract][Full Text] [Related]
17. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
Hashimoto T; Nishino N; Nakai H; Tanaka C
Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
[TBL] [Abstract][Full Text] [Related]
18. A potential 5-HT1A receptor antagonist: p-MPPI.
Kung HF; Kung MP; Clarke W; Maayani S; Zhuang ZP
Life Sci; 1994; 55(19):1459-62. PubMed ID: 7968212
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
20. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
Ahlers ST; Weissman BA; Barrett JE
J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
